BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9390216)

  • 1. Adenomyomatous polyp of the uterus in a patient receiving tamoxifen.
    Nasu K; Arima K; Yoshimatsu J; Miyakawa I
    Jpn J Clin Oncol; 1997 Oct; 27(5):350-2. PubMed ID: 9390216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of adenomyomatous polyp of the uterus associated with tamoxifen therapy.
    Takeuchi M; Matsuzaki K; Uehara H; Shimazu H; Nishitani H
    Radiat Med; 2005 Sep; 23(6):432-4. PubMed ID: 16389986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen.
    Nasu K; Miyazaki T; Kiyonaga Y; Kawasaki F; Miyakawa I
    Gynecol Obstet Invest; 1999; 48(3):200-2. PubMed ID: 10545747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
    Liu IF; Yen YS; Cheng YM; Chou CY
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenomyomatous polyp of the endometrium: a case report.
    Fitzhugh VA; Murphy G; Heller DS
    J Reprod Med; 2008 Mar; 53(3):231-4. PubMed ID: 18441733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic liposarcoma of the uterus: case report and literature review.
    Levine PH; Wei XJ; Gagner JP; Flax H; Mittal K; Blank SV
    Int J Gynecol Pathol; 2003 Oct; 22(4):407-11. PubMed ID: 14501826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomatous polyp--cause of postmenopausal bleeding in a breast cancer patient treated with tamoxifen.
    Jahoorahmad PZ; Yatindra K; Jitendra VJ
    Singapore Med J; 2003 Jul; 44(7):359. PubMed ID: 14620729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
    Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
    Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.
    Bertelli G; Queirolo P; Vecchio S; Angiolini C; Bergaglio M; Del Mastro L; Signorini A; Valenzano M; Venturini M
    Anticancer Res; 2000; 20(5C):3659-61. PubMed ID: 11268435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.
    Maenaka T; Egawa-Takata T; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
    J Obstet Gynaecol Res; 2014 May; 40(5):1450-4. PubMed ID: 24606575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.